TABLE 1.
In vitro activities of telavancin (TD-6424) against 271 recent clinical isolates of gram-positive anaerobes and corynebacteria
Antimicrobial | MIC (μg/ml)a
|
Antimicrobial | MIC (μg/ml)a
|
|||||
---|---|---|---|---|---|---|---|---|
Range | 50% | 90% | Range | 50% | 90% | |||
Actinomyces israelii (n = 13) | ||||||||
Telavancin | 0.125-0.25 | 0.25 | 0.25 | |||||
Daptomycin | 0.5->32 | 2 | 4 | |||||
Vancomycin | 0.5-1 | 0.5 | 1 | |||||
Linezolid | 0.25-16 | 0.5 | 16 | |||||
Quinupristin-dalfopristin | 0.125-0.5 | 0.25 | 0.25 | |||||
Imipenem | ≤0.03-0.25 | ≤0.03 | 0.125 | |||||
Piperacillin-tazobactam | ≤0.03-4 | ≤0.03 | 4 | |||||
Ampicillin | ≤0.03-0.5 | ≤0.03 | 0.5 | |||||
Actinomyces meyeri-A. turicensis groupb (n = 12) | ||||||||
Telavancin | 0.125-0.25 | 0.125 | 0.25 | |||||
Daptomycin | 0.5-16 | 2 | 8 | |||||
Vancomycin | 0.25-1 | 0.5 | 0.5 | |||||
Linezolid | 0.125-1 | 0.5 | 0.5 | |||||
Quinupristin-dalfopristin | 0.06-0.5 | 0.125 | 0.125 | |||||
Imipenem | ≤0.03-0.125 | 0.125 | 0.125 | |||||
Piperacillin-tazobactam | ≤0.03-2 | 0.5 | 1 | |||||
Ampicillin | 0.125-0.5 | 0.25 | 0.5 | |||||
Actinomyces odontolyticus (n = 10) | ||||||||
Telavancin | 0.125-0.25 | 0.25 | 0.25 | |||||
Daptomycin | 16->32 | 16 | 32 | |||||
Vancomycin | 0.5-1 | 1 | 1 | |||||
Linezolid | 0.5-1 | 0.5 | 0.5 | |||||
Quinupristin-dalfopristin | 0.125-0.5 | 0.25 | 0.25 | |||||
Imipenem | 0.06-0.25 | 0.125 | 0.125 | |||||
Piperacillin-tazobactam | 0.25-4 | 1 | 4 | |||||
Ampicillin | 0.06-0.5 | 0.125 | 0.5 | |||||
Actinomyces viscosus (n = 10) | ||||||||
Telavancin | 0.125-0.25 | 0.125 | 0.25 | |||||
Daptomycin | 0.5-8 | 4 | 8 | |||||
Vancomycin | 0.5-0.5 | 0.5 | 0.5 | |||||
Linezolid | 0.5-0.5 | 0.5 | 0.5 | |||||
Quinupristin-dalfopristin | 0.06-0.5 | 0.25 | 0.25 | |||||
Imipenem | ≤0.03-≤0.03 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-0.5 | 0.125 | 0.5 | |||||
Ampicillin | ≤0.03-0.06 | 0.06 | 0.06 | |||||
Clostridium clostridioforme (n = 15) | ||||||||
Telavancin | 0.25-8 | 1 | 8 | |||||
Daptomycin | 0.25-8 | 1 | 4 | |||||
Vancomycin | 0.25->32 | 0.5 | 1 | |||||
Linezolid | 2-4 | 2 | 4 | |||||
Quinupristin-dalfopristin | 0.125-8 | 0.5 | 4 | |||||
Imipenem | 0.5-2 | 1 | 2 | |||||
Piperacillin-tazobactam | 0.25-64 | 4 | 8 | |||||
Ampicillin | 0.5->32 | 1 | 1 | |||||
Clostridium difficile (n = 14) | ||||||||
Telavancin | 0.125-0.5 | 0.25 | 0.25 | |||||
Daptomycin | 0.5-2 | 0.5 | 2 | |||||
Vancomycin | 0.25-2 | 0.5 | 1 | |||||
Linezolid | 2-8 | 2 | 8 | |||||
Quinupristin-dalfopristin | 0.25-2 | 0.25 | 1 | |||||
Imipenem | 2-32 | 4 | 8 | |||||
Piperacillin-tazobactam | 4-16 | 8 | 16 | |||||
Ampicillin | 0.5-2 | 1 | 2 | |||||
Clostridium innocuum (n = 15) | ||||||||
Telavancin | 2-4 | 4 | 4 | |||||
Daptomycin | 2-8 | 4 | 8 | |||||
Vancomycin | 8-16 | 16 | 16 | |||||
Linezolid | 2-4 | 2 | 2 | |||||
Quinupristin-dalfopristin | 0.125-1 | 0.25 | 0.25 | |||||
Imipenem | 1-2 | 2 | 2 | |||||
Piperacillin-tazobactam | 0.5-4 | 1 | 2 | |||||
Ampicillin | 0.125-0.25 | 0.125 | 0.25 | |||||
Clostridium perfringens (n = 12) | ||||||||
Telavancin | 0.06-0.125 | 0.06 | 0.125 | |||||
Daptomycin | 0.25-1 | 1 | 1 | |||||
Vancomycin | 0.5-0.5 | 0.5 | 0.5 | |||||
Linezolid | 2-2 | 2 | 2 | |||||
Quinupristin-dalfopristin | 0.125-0.5 | 0.25 | 0.5 | |||||
Imipenem | ≤0.03-0.25 | 0.06 | 0.125 | |||||
Piperacillin-tazobactam | ≤.03-2 | 0.06 | 0.5 | |||||
Ampicillin | ≤0.03-0.06 | ≤0.03 | 0.06 | |||||
Clostridium ramosum (n = 16) | ||||||||
Telavancin | 0.25-8 | 0.5 | 1 | |||||
Daptomycin | 8->32 | 32 | 32 | |||||
Vancomycin | 1-8 | 4 | 4 | |||||
Linezolid | 4-8 | 8 | 8 | |||||
Quinupristin-dalfopristin | 0.125-2 | 0.25 | 2 | |||||
Imipenem | 0.125-2 | 0.25 | 0.5 | |||||
Piperacillin-tazobactam | ≤0.03-1 | 0.06 | 0.5 | |||||
Ampicillin | ≤0.03-1 | 0.06 | 0.25 | |||||
Eubacterium lentum (n = 10) | ||||||||
Telavancin | 0.125-0.25 | 0.25 | 0.25 | |||||
Daptomycin | 1-32 | 16 | 32 | |||||
Vancomycin | 0.5-1 | 1 | 1 | |||||
Linezolid | 0.5-2 | 2 | 2 | |||||
Quinupristin-dalfopristin | 0.125-0.5 | 0.25 | 0.5 | |||||
Imipenem | ≤0.03-0.25 | 0.25 | 0.25 | |||||
Piperacillin-tazobactam | ≤0.03-32 | 16 | 16 | |||||
Ampicillin | ≤0.03-0.5 | 0.25 | 0.5 | |||||
Eubacterium limosum (n = 10) | ||||||||
Telavancin | 0.06-0.25 | 0.125 | 0.25 | |||||
Daptomycin | 0.06-0.5 | 0.25 | 0.25 | |||||
Vancomycin | 0.25-2 | 2 | 2 | |||||
Linezolid | 1-4 | 2 | 4 | |||||
Quinupristin-dalfopristin | 0.125-2 | 0.25 | 1 | |||||
Imipenem | ≤0.03-≤0.03 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-2 | ≤0.03 | 0.25 | |||||
Ampicillin | ≤0.03-0.125 | ≤0.03 | 0.06 | |||||
Eubacterium groupc (n = 13) | ||||||||
Telavancin | 0.03-1 | 0.25 | 0.25 | |||||
Daptomycin | 0.06-8 | 0.5 | 0.5 | |||||
Vancomycin | 0.25-4 | 1 | 2 | |||||
Linezolid | 0.5-2 | 2 | 2 | |||||
Quinupristin-dalfopristin | ≤0.03-1 | 0.5 | 1 | |||||
Imipenem | ≤0.03-0.125 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-0.5 | ≤0.03 | 0.5 | |||||
Ampicillin | ≤0.03-0.125 | ≤0.03 | 0.06 | |||||
Lactobacillus plantarum (n = 10) | ||||||||
Telavancin | 0.125-0.25 | 0.25 | 0.25 | |||||
Daptomycin | 8->32 | 32 | >32 | |||||
Vancomycin | 0.5-4 | 4 | 4 | |||||
Linezolid | 4-8 | 8 | 8 | |||||
Quinupristin-dalfopristin | 0.5-2 | 0.5 | 2 | |||||
Imipenem | 0.125-0.5 | 0.125 | 0.25 | |||||
Piperacillin-tazobactam | ≤0.03-1 | 0.06 | 0.5 | |||||
Ampicillin | ≤0.03-0.5 | ≤0.03 | 0.25 | |||||
Lactobacillus casei (n = 6) | ||||||||
Telavancin | 32->64 | 32 | ||||||
Daptomycin | 1-4 | 2 | ||||||
Vancomycin | >32->32 | >32 | ||||||
Linezolid | 4 | 4 | ||||||
Quinupristin-dalfopristin | 0.5-1 | 1 | ||||||
Imipenem | 1-16 | 2 | ||||||
Piperacillin-tazobactam | 1-8 | 4 | ||||||
Ampicillin | 0.5-4 | 1 | ||||||
Lactobacillus sp.d (n = 16) | ||||||||
Telavancin | ≤0.015-2 | 0.25 | 1.25 | |||||
Daptomycin | 0.25->32 | 4 | >32 | |||||
Vancomycin | 0.25-8 | 1 | 4 | |||||
Linezolid | 1-8 | 4 | 8 | |||||
Quinupristin-dalfopristin | 0.125-4 | 0.25 | 1 | |||||
Imipenem | ≤0.03-1 | 0.06 | 0.25 | |||||
Piperacillin-tazobactam | ≤0.03-1 | 0.25 | 1 | |||||
Ampicillin | ≤0.03-1 | 0.125 | 0.5 | |||||
Propionibacterium acnes (n = 12) | ||||||||
Telavancin | 0.06-0.125 | 0.125 | 0.125 | |||||
Daptomycin | 0.125-1 | 0.5 | 1 | |||||
Vancomycin | 0.25-0.5 | 0.5 | 0.5 | |||||
Linezolid | 0.25-0.5 | 0.5 | 0.5 | |||||
Quinupristin-dalfopristin | ≤0.03-0.5 | 0.125 | 0.125 | |||||
Imipenem | ≤0.03-≤.03 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-0.5 | 0.125 | 0.5 | |||||
Ampicillin | ≤0.03-0.125 | 0.06 | 0.06 | |||||
Propionibacterium avidum (n = 12) | ||||||||
Telavancin | 0.125-0.25 | 0.125 | 0.125 | |||||
Daptomycin | 1-2 | 2 | 2 | |||||
Vancomycin | 0.5-0.5 | 0.5 | 0.5 | |||||
Linezolid | 0.5-1 | 0.5 | 0.5 | |||||
Quinupristin-dalfopristin | 0.125-0.125 | 0.125 | 0.125 | |||||
Imipenem | ≤0.03-≤0.03 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-1 | 0.5 | 1 | |||||
Ampicillin | ≤0.03-0.125 | 0.125 | 0.125 | |||||
Propionibacterium granulosum (n = 10) | ||||||||
Telavancin | 0.06-0.125 | 0.06 | 0.125 | |||||
Daptomycin | 0.125-1 | 0.5 | 1 | |||||
Vancomycin | 0.5-1 | 0.5 | 1 | |||||
Linezolid | 0.25-0.5 | 0.25 | 0.25 | |||||
Quinupristin-dalfopristin | 0.06-0.125 | 0.125 | 0.125 | |||||
Imipenem | ≤0.03-0.06 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-1 | ≤0.03 | ≤0.03 | |||||
Ampicillin | ≤0.03-0.5 | 0.06 | 0.06 | |||||
Peptostreptococcus anaerobius (n = 10) | ||||||||
Telavancin | 0.06-0.25 | 0.06 | 0.25 | |||||
Daptomycin | 0.25-4 | 0.25 | 0.5 | |||||
Vancomycin | 0.25-0.5 | 0.25 | 0.5 | |||||
Linezolid | 0.5-8 | 0.5 | 8 | |||||
Quinupristin-dalfopristin | 0.06-0.5 | 0.125 | 0.25 | |||||
Imipenem | ≤0.03-0.06 | ≤0.03 | 0.06 | |||||
Piperacillin-tazobactam | ≤0.03-1 | 0.25 | 0.25 | |||||
Ampicillin | ≤0.03-0.125 | 0.06 | 0.125 | |||||
Peptoniphilus asaccharolyticuse (n = 10) | ||||||||
Telavancin | 00.03-0.06 | 00.03 | 0.06 | |||||
Daptomycin | ≤0.03-0.25 | ≤0.03 | ≤0.03 | |||||
Vancomycin | 0.06-0.5 | 0.125 | 0.125 | |||||
Linezolid | 0.5-1 | 0.5 | 1 | |||||
Quinupristin-dalfopristin | 0.25-0.5 | 0.5 | 0.5 | |||||
Imipenem | ≤0.03-≤0.03 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-0.06 | ≤0.03 | ≤0.03 | |||||
Ampicillin | ≤0.03-0.125 | ≤0.03 | 0.06 | |||||
Finegoldia magnae (n = 11) | ||||||||
Telavancin | 00.03-0.25 | 0.06 | 0.06 | |||||
Daptomycin | 0.25-4 | 0.5 | 1 | |||||
Vancomycin | 0.25-1 | 0.25 | 0.5 | |||||
Linezolid | 0.5-2 | 1 | 2 | |||||
Quinupristin-dalfopristin | 0.25-0.5 | 0.25 | 0.5 | |||||
Imipenem | ≤0.03-0.125 | ≤0.03 | 0.125 | |||||
Piperacillin-tazobactam | ≤0.03-0.5 | 0.125 | 0.5 | |||||
Ampicillin | ≤0.03-0.25 | 0.125 | 0.25 | |||||
Micromonas microse (n = 10) | ||||||||
Telavancin | 0.06-0.125 | 0.06 | 0.125 | |||||
Daptomycin | 0.25-1 | 0.5 | 0.5 | |||||
Vancomycin | 0.25-0.5 | 0.5 | 0.5 | |||||
Linezolid | 0.5-1 | 0.5 | 1 | |||||
Quinupristin-dalfopristin | 0.5-1 | 0.5 | 1 | |||||
Imipenem | ≤0.03-0.125 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-0.25 | ≤0.03 | ≤0.03 | |||||
Ampicillin | ≤0.03-≤0.03 | ≤0.03 | ≤0.03 | |||||
Anaerococcus prevotiie (n = 11) | ||||||||
Telavancin | ≤.015-0.5 | 0.03 | 0.06 | |||||
Daptomycin | ≤0.03-16 | 0.06 | 0.125 | |||||
Vancomycin | 0.125-1 | 0.5 | 0.5 | |||||
Linezolid | ≤0.03-2 | 0.5 | 1 | |||||
Quinupristin-dalfopristin | ≤0.03-1 | 0.25 | 0.5 | |||||
Imipenem | ≤0.03-0.06 | ≤0.03 | ≤0.03 | |||||
Piperacillin-tazobactam | ≤0.03-0.125 | ≤0.03 | 0.06 | |||||
Ampicillin | ≤0.03-0.125 | ≤0.03 | 0.06 | |||||
Corynebacterium amycolatum (n = 10) | ||||||||
Telavancin | 0.03-0.06 | 0.03 | 0.06 | |||||
Daptomycin | ≤0.03-0.125 | 0.06 | 0.06 | |||||
Vancomycin | 0.25-0.5 | 0.5 | 0.5 | |||||
Linezolid | 0.25-0.5 | 0.5 | 0.5 | |||||
Quinupristin-dalfopristin | 0.125-0.25 | 0.25 | 0.25 | |||||
Imipenem | ≤0.03->32 | 0.125 | >32 | |||||
Piperacillin-tazobactam | ≤0.03->128 | 4 | >128 | |||||
Ampicillin | 0.06->32 | 2 | >32 | |||||
Corynebacterium jeikeium (n = 11) | ||||||||
Telavancin | 0.03-0.06 | 0.06 | 0.06 | |||||
Daptomycin | 0.125-0.5 | 0.25 | 0.5 | |||||
Vancomycin | 0.5-0.5 | 0.5 | 0.5 | |||||
Linezolid | 0.5-0.5 | 0.5 | 0.5 | |||||
Quinupristin-dalfopristin | 0.25-1 | 0.25 | 0.5 | |||||
Imipenem | 1->32 | >32 | >32 | |||||
Piperacillin-tazobactam | 64->128 | >128 | >128 | |||||
Ampicillin | >32->32 | >32 | >32 | |||||
Corynebacterium groupf (n = 10) | ||||||||
Telavancin | ≤0.015-0.03 | ≤0.015 | 0.03 | |||||
Daptomycin | ≤0.03-0.125 | 0.06 | 0.06 | |||||
Vancomycin | 0.125-0.5 | 0.25 | 0.5 | |||||
Linezolid | 0.125-0.5 | 0.25 | 0.5 | |||||
Quinupristin-dalfopristin | 0.125-2 | 0.5 | 0.5 | |||||
Imipenem | ≤0.03->32 | 0.04 | 32 | |||||
Piperacillin-tazobactam | ≤0.03->128 | 4 | 32 | |||||
Ampicillin | ≤0.03->32 | 0.5 | 32 |
50% and 90%, MIC50 and MIC90, respectively.
A. meyeri (n = 5) and A. turicensis (n = 7).
E. contortum (n = 2), E. moniliforme (n = 1), E. tenue (n = 2), Pseudoramibacter alactolyticus (n = 7), and Eubacterium sp., no good fit (n = 1).
Includes L. acidophilus (n = 2), L. catenaforme (n = 8), L. gasseri (n = 1). L. jensenii (n = 2), L. leichmannii (n = 1), L. rhamnosus (n = 1), and L. uli (n = 1).
Formerly Peptostreptococcus.
C. pseudodiphtheriticum (n = 3), C. striatum (n = 6), and Brevibacterium sp. (n = 1).